Navigation Links
New data showed type 2 diabetes patients experienced greater blood sugar reductions
Date:10/15/2009

DEERFIELD, Ill., October 14, 2009 A study, published online in the journal Current Medical Research and Opinion, showed that a greater percentage of patients with type 2 diabetes treated with the fixed-dose combination ACTOplus met (pioglitazone HCl and metformin HCl) as initial therapy reached the study goal of hemoglobin A1c (HbA1c) of ≤7 percent compared to either component alone. Safety and tolerability of ACTOplus met therapy were evaluated by rate of drug discontinuation and treatment-emergent adverse events.

"Diabetes is a progressive and chronic condition, which requires continued monitoring by a patient and physician. In addition to diet and exercise, patients often need to take multiple medications to help them manage their glucose control," said Robert Spanheimer, M.D., vice president of medical and scientific affairs, Takeda Pharmaceuticals North America, Inc. "We are pleased to see that this study was successful in meeting its intended endpoints. A greater number of patients reached the blood sugar target of less than 7 percent, as recommended by the American Diabetes Association, using combination therapy as initial treatment compared with either single treatment alone."

Upon completion of the study, all treatment groups achieved statistically significant HbA1c reductions (p<0.001) from a baseline HbA1c of 8.7, and the greatest decrease was observed in patients treated with ACTOplus met (15 mg/850 mg twice daily) (-1.83 percent versus 0.99 percent and 0.96 percent with ACTOS (pioglitazone HCl) (15 mg twice daily) or metformin (850 mg twice daily), respectively). The endpoint responder rates were higher in the ACTOplus met group, with 64 percent of patients reaching HbA1c goal of ≤7 percent compared to ACTOS (46 percent) or metformin (39 percent) alone.

The overall treatment-emergent adverse events were 50.7 percent for the ACTOplus met group; 52.1 percent for the ACTOS group; and 53.1 percent for the metfo
'/>"/>

Contact: Carrie Rose
carrie.rose@ketchum.com
646-935-3938
Takeda Pharmaceuticals North America
Source:Eurekalert

Page: 1 2 3 4 5

Related medicine news :

1. Study Published in The Lancet Showed Significant Survival Benefit for Patients Facing Deadly Form of Lung Cancer
2. Video: Phase III Head to Head Trial Showed Ticagrelor Reduced Cardiovascular Death and Heart Attacks Over Clopidogrel in Acute Coronary Syndromes Patients
3. Use of Mealtime Pramlintide Added to Basal Insulin Showed Similar Improvements in Glycemic Control Compared to Rapid-Acting Insulin, With Lower Risk of Hypoglycemia and Without Weight Gain: Data Presented at ADA 2009
4. Study Showed New Episodes of Depression Delayed in People Taking Cymbalta(R)
5. Study Showed ALIMTA(R) (pemetrexed for injection) Improved Survival in Certain Types of Non-Small Cell Lung Cancer
6. Shire investigational nonstimulant INTUNIV showed significant efficacy in reducing ADHD symptoms
7. Study Showed Minimally Invasive Surgery Reduced Risk of Hospital-Acquired Infections Compared to Open Surgery
8. New data showed Actos prevented progression of atherosclerotic plaque volume in patients
9. Phase III Trial of VELCADE(R) (Bortezomib) for Injection Showed Dramatic Fourfold Increase in Complete Remission Rates When Combined With the Most Commonly Used U.S. Regimen in Front-Line Multiple Myeloma
10. Monotherapy BYETTA(R) Showed Significant Improvement in Glucose Control and Weight Loss in Adults with Type 2 Diabetes
11. Once-Weekly Exenatide Showed Statistical Superiority in Glucose Control Compared to BYETTA in Head-to-Head Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... ... 07, 2015 , ... SC&H Group, a leading audit, tax, and consulting firm, ... the community through company-wide volunteering efforts. , On an annual basis, in coordination with ... those in need throughout Baltimore and Washington D.C. , This year, SC&H ...
(Date:7/7/2015)... Hong Kong (PRWEB) , ... July 07, 2015 , ... At the end of June ... first steps to ‘go green’ . This initiative, spearheaded by the Renewals Manager, Danielle Cotton, ... Hong Kong office. , On this initiative Cotton explained, “We send anything between 300 ...
(Date:7/7/2015)... R.I. (PRWEB) , ... July 07, 2015 , ... Summer ... the proper precautions, however, so Amica Insurance is sharing some safety tips. , Jean ... sports and gardening: , Leisure activities/sports, , Start slowly. Going ...
(Date:7/7/2015)... ... July 07, 2015 , ... Healthpointe is proud to ... Alupay, an anesthesiologist and pain management specialist, will be evaluating and treating patients with ... conditions. , After receiving his Bachelor of Science in Biology from the University of ...
(Date:7/7/2015)... ... 07, 2015 , ... Parents and guardians of teenagers or young adults will ... holistic treatment center for drug and alcohol abuse located in Southwest Michigan. A recently ... shown a significant increase in the “club drug” use among high school seniors. The ...
Breaking Medicine News(10 mins):Health News:SC&H Group Celebrates 9th Annual Day of Service 2Health News:Pacific Prime Hong Kong Renewals Team Starts Push to go Green 2Health News:Amica Insurance Has 7 Summer Safety Tips 2Health News:Dr. Pedro S. Alupay, M.D., Now Providing Pain Management Services at Healthpointe in Irwindale 2Health News:Dr. Pedro S. Alupay, M.D., Now Providing Pain Management Services at Healthpointe in Irwindale 3Health News:A Forever Recovery Releases New Information on “Club Drugs” and Tips for Parents of Teens and Young Adults 2
... Sheets: USFM ), announces the launch of ... which will operate as a division of US Farms Inc. ... wholesales for $89.95 per case (12 bottles). US Farms Aloe Vera ... American Express or by calling customer service 877-90-FARMS. , , ...
... play a pivotal role in moving services into less expensive yet clinically ... and policy firm KNG Health Consulting. Other key findings from the study, ... 2007, include: , , , , ... and cancer screening services. , 70% ...
... ... it is the first home health agency in California to implement an ... to improve health care. This home health software service equips all ... the point of care, reduces costs, improves efficiency and enhances communication across ...
... , MINNEAPOLIS, June 16 Excell Home Care & ... hospice services in Oklahoma, announced it has entered into ... telehealth technology to patients with chronic illness. Cardiocom, ... manufacturer and clinical service provider of award-winning telehealth solutions. ...
... injectable nano-emulsion formulated with, AlphaRx,s proprietary drug ... behavioral models. Gaia BioPharma plans to, initiate ... acute and as yet, unmet neurological indication., ... Inc. (OTCBB: ALRX) and Gaia BioPharma Limited, a privately held, ...
... Governor Pat Quinn and Mayor Richard Daley Declare June 27, 2009 ... State of Illinois , , CHICAGO, June 16 ... Chicago Hispanic Health Coalition to present Chicago,s third-annual Vive ... The event promotes family physical activity for better health and ...
Cached Medicine News:Health News:US Farms, Inc. Launches Aloe Vera Juice Web Site for Hispanic Market 2Health News:US Farms, Inc. Launches Aloe Vera Juice Web Site for Hispanic Market 3Health News:Ambulatory Surgery Centers 'Pivotal' in Moving Outpatient Surgical Services Into Less Expensive, Clinically Appropriate Settings 2Health News:Ambulatory Surgery Centers 'Pivotal' in Moving Outpatient Surgical Services Into Less Expensive, Clinically Appropriate Settings 3Health News:Ambulatory Surgery Centers 'Pivotal' in Moving Outpatient Surgical Services Into Less Expensive, Clinically Appropriate Settings 4Health News:Ambulatory Surgery Centers 'Pivotal' in Moving Outpatient Surgical Services Into Less Expensive, Clinically Appropriate Settings 5Health News:New Online Home Health Service Launched in California to Expand Direct Patient Care Time While Lowering Costs 2Health News:New Online Home Health Service Launched in California to Expand Direct Patient Care Time While Lowering Costs 3Health News:Excell Home Care & Hospice, Inc. Selects Cardiocom Telehealth Technology 2Health News:AlphaRx and Gaia BioPharma Provide GAI-122 Development Update 2Health News:Chicago Hispanic Health Coalition Presents Third-Annual Vive tu Vida! Get Up! Get Moving!(TM) Event 2
(Date:7/7/2015)... Research and Markets( http://www.researchandmarkets.com/research/hmdflj/outlook_of_global ) has ... Biologic Drug Discovery Outsourcing Market" report to their ... market will likely grow in a CAGR of 23% ... by 2020. It has been widely recognized ... new but important type of medication. They provide not ...
(Date:7/7/2015)... June 30, 2015 ... addition of the "Deciphering Global Major Pharmaceutical ... to their offering. It has been ... been involved in a series of challenges in ... resulted in significant overcapacities in small molecule product ...
(Date:7/7/2015)... , July 7, 2015   Decision Resources ... differences in dialysis patient management in the U.S. ... submitted by U.S. and EU5 nephrologists from approximately ... binders are the most commonly used renal medications ... iron differs considerably between the two regions.      ...
Breaking Medicine Technology:Outlook of Global Biologic Drug Discovery Outsourcing Market to 2020 2Outlook of Global Biologic Drug Discovery Outsourcing Market to 2020 3Deciphering Global Major Pharmaceutical Companies - New Outsourcing Demands and Strategies 2Deciphering Global Major Pharmaceutical Companies - New Outsourcing Demands and Strategies 3Similarities And Differences Exist When Comparing U.S. Versus EU5 Dialysis Patient Management 2Similarities And Differences Exist When Comparing U.S. Versus EU5 Dialysis Patient Management 3
... PASADENA, Calif. March 2, 2011 Men who take non-steroidal ... months are 2.4 times more likely to have erectile dysfunction ... according to a Kaiser Permanente study published online in ... research showed a trend toward this same finding, this observational ...
... The U.S. Food and Drug Administration today took ... unapproved prescription oral cough, cold, and allergy products. The ... States. (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO ) ... have not been evaluated by the FDA for safety, ...
Cached Medicine Technology:Non-Steroidal Anti-Inflammatory Drugs Linked to Increased Risk of Erectile Dysfunction 2Non-Steroidal Anti-Inflammatory Drugs Linked to Increased Risk of Erectile Dysfunction 3FDA Prompts Removal of Unapproved Drugs From Market 2FDA Prompts Removal of Unapproved Drugs From Market 3
... The modular Doro headrest system ... and non-invasive applications in head ... be adapted to all standard ... decisive advantages and improvements in ...
Bunnel hand drill with Jacobs chuck, chuck size 4 mm....
Children's hospital hand drill, hexagonal handle, twist drill diameter 4.2 mm....
Hudson Drill hand drill....
Medicine Products: